These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

489 related items for PubMed ID: 18446593

  • 1. Costs and resource use of mild persistent asthma patients initiated on controller therapy.
    Colice GL, Yu AP, Ivanova JI, Hsieh M, Birnbaum HG, Lage MJ, Brewster C.
    J Asthma; 2008 May; 45(4):293-9. PubMed ID: 18446593
    [Abstract] [Full Text] [Related]

  • 2. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS, Yawn BP.
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [Abstract] [Full Text] [Related]

  • 3. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
    Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
    Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
    [Abstract] [Full Text] [Related]

  • 6. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM, Riemersma RA, Postma DS, van der Molen T, Rutten-van Mölken MP.
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [Abstract] [Full Text] [Related]

  • 7. Asthma costs and utilization in a managed care organization.
    Zeiger RS, Hay JW, Contreras R, Chen W, Quinn VP, Seal B, Schatz M.
    J Allergy Clin Immunol; 2008 Apr; 121(4):885-92.e5. PubMed ID: 18313133
    [Abstract] [Full Text] [Related]

  • 8. Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities.
    O'Connor RD, Parasuraman B, Roberts C, Leibman C.
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):236-43. PubMed ID: 16937758
    [Abstract] [Full Text] [Related]

  • 9. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Asthma rescue and allergy medication use among asthmatic children with prior allergy prescriptions who initiated asthma controller therapy.
    Luskin A, Bukstein D, Kocevar VS, Yin DD.
    Ann Allergy Asthma Immunol; 2005 Aug; 95(2):129-36. PubMed ID: 16136761
    [Abstract] [Full Text] [Related]

  • 16. Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.
    Gagnon YM, Levy AR, Spencer MD, Hurley JS, Frost FJ, Mapel DW, Briggs AH.
    Respir Med; 2005 Dec; 99(12):1534-45. PubMed ID: 16291076
    [Abstract] [Full Text] [Related]

  • 17. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.
    Lafeuille MH, Dean J, Zhang J, Duh MS, Gorsh B, Lefebvre P.
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):59-64. PubMed ID: 22727159
    [Abstract] [Full Text] [Related]

  • 18. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S, Vogelmeier C, Buhl R.
    Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
    [Abstract] [Full Text] [Related]

  • 19. Considering therapeutic options in the real world.
    Martin RJ.
    J Allergy Clin Immunol; 2003 Nov 15; 112(5 Suppl):S112-5. PubMed ID: 14586396
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z, Dekhuijzen PN.
    Ned Tijdschr Geneeskd; 2003 Aug 30; 147(35):1681-5. PubMed ID: 14513539
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.